Effects of magnetic cobalt ferrite nanoparticles on biological and artificial lipid membranes

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1559-1581

  Drašler, Barbara ^a   Drobne, Damjana ^a,b,c   Novak, Sara ^a   Valant, Janez ^a   Boljte, Sabina ^a,d   Otrin, Lado ^a   Rappolt, Michael ^e,f   Sartori, Barbara ^e   Iglič, Aleš ^a   Kralj Iglič, Veronika ^a   Šuštar, Vid ^a   Makovec, Darko ^c,g   Gyergyek, Sašo ^g   Hočevar, Matej ^h   Godec, Matjaž ^h   Zupanc, Jernej ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Centre of Excellence in Advanced Materials Technologies for the Future (NAMASTE)   (Slovenia)

^c Centre of Excellence in Nanoscience and Nanotechnology (Nanocenter)   (Slovenia)

^d Inst for Metal Mat and Technol   (Slovenia)

^e GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g JO EF STEFAN INSTITUTE   (Slovenia)

^h INSTITUTE OF METALS AND TECHNOLOGY   (Slovenia)

Author keywords

Agglomerates; Human red blood cells; Lipid vesicles; Nanoparticles

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; CITRIC ACID; COBALT; FERRITE; GLUCOSE; NANOPARTICLE; PHOSPHATE BUFFERED SALINE;

ANTIGEN ANTIBODY REACTION; ARTICLE; ARTIFICIAL MEMBRANE; COMPUTER ANALYSIS; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; HEMOLYSIS; HUMAN; HUMAN CELL; IMAGING; LIPID MEMBRANE; LIPID VESICLE; MAGNETISM; MEMBRANE BIOLOGY; MEMBRANE STRUCTURE; MEMBRANE VESICLE; PHASE CONTRAST MICROSCOPY; SCANNING ELECTRON MICROSCOPY; SEDIMENTATION; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY;

AGGLOMERATES; COFE2O4; HUMAN RED BLOOD CELLS; LIPID VESICLES; NANOPARTICLES;

CELLS, CULTURED; COBALT; ERYTHROCYTE MEMBRANE; HUMANS; LIPID BILAYERS; MAGNETITE NANOPARTICLES; MATERIALS TESTING; MEMBRANE FLUIDITY; MOLECULAR CONFORMATION; PHOSPHATIDYLCHOLINES;

EID: 84897094728     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57671     Document Type: Article

References (69)

1. de Planque MRR, Aghdaei S, Roose T, Morgan H. Electrophysiological characterization of membrane disruption by nanoparticles. ACS Nano. 2011;5(5):3599-3606.
2. Thanh NTK, Green LAW. Functionalisation of nanoparticles for biomedical applications. Nano Today. 2010;5(3):213-230.
3. Grigorova M, Blythe HJ, Blaskov V, et al. Magnetic properties and Mossbauer spectra of nanosized CoFe(2)O(4) powders. J Magn Magn Mater. 1998;183(1-2):163-172.
4. Kita E, Oda T, Kayano T, et al. Ferromagnetic nanoparticles for magnetic hyperthermia and thermoablation therapy. J Phys D Appl Phys. 2010;43(47):474011.
5. Baldi G, Bonacchi D, Innocenti C, Lorenzi G, Sangregorio C. Cobalt ferrite nanoparticles: the control of the particle size and surface state and their effects on magnetic properties. J Magn Magn Mater. 2007;311(1): 10-16.
6. Verde EL, Landi GT, Gomes JA, Sousa MH, Bakuzis AF. Magnetic hyperthermia investigation of cobalt ferrite nanoparticles: comparison between experiment, linear response theory, and dynamic hysteresis simulations. J Appl Phys. 2012;111(12).
7. Marmorato P, Ceccone G, Gianoncelli A, et al. Cellular distribution and degradation of cobalt ferrite nanoparticles in Balb/3T3 mouse fibroblasts. Toxicol Lett. 2011;207(2):128-136.
8. Wang EC, Wang AZ. Nanoparticles and their applications in cell and molecular biology. Integr Biol (Camb). 2013;6(1):9-26.
9. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-149.
10. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6(1):12-21.
11. Leroueil PR, Hong S, Mecke A, Baker JR Jr, Orr BG, Banaszak Holl MM. Nanoparticle interaction with biological membranes: does nanotechnology present a janus face? Acc Chem Res. 2007;40(5):335-342.
12. Dawson KA, Salvati A, Lynch I. Nanoparticles reconstruct lipids. Nat Nanotechnol. 2009;4(2):84-85.
13. da Rocha EL, Caramori GF, Rambo CR. Nanoparticle translocation through a lipid bilayer tuned by surface chemistry. Phys Chem Chem Phys. 2013;15(7):2282-2290.
14. Wang B, Zhang LF, Bae SC, Granick S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci U S A. 2008;105(47):18171-18175.
15. Yu Y, Granick S. Pearling of lipid vesicles induced by nanoparticles. J Am Chem Soc. 2009;131(40):14158-14159.
16. Chen R, Choudhary P, Schurr RN, Bhattacharya P, Brown JM, Ke PC. Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett. 2012;100(1):13703-137034.
17. Roiter Y, Ornatska M, Rammohan AR, Balakrishnan J, Heine DR, Minko S. Interaction of nanoparticles with lipid membrane. Nano Lett. 2008;8(3):941-944.
18. Thomassen LC, Rabolli V, Masschaele K, et al. Model system to study the influence of aggregation on the hemolytic potential of silica nanoparticles. Chem Res Toxicol. 2011;24(11):1869-1875.
19. Westerhausen C, Strobl FG, Herrmann R, et al. Chemical and mechanical impact of silica nanoparticles on the phase transition behavior of phospholipid membranes in theory and experiment. Biophys J. 2012;102(5):1032-1038.
20. Fosnaric M, Iglic A, Kroll DM, May S. Monte Carlo simulations of complex formation between a mixed fluid vesicle and a charged colloid. J Chem Phys. 2009;131(10):105103.
21. Hong SP, Leroueil PR, Janus EK, et al. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem. 2006;17(3): 728-734.
22. Leroueil PR, Berry SA, Duthie K, et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 2008;8(2):420-424.
23. Anderson TH, Min YJ, Weirich KL, Zeng HB, Fygenson D, Israelachvili JN. Formation of supported bilayers on silica substrates. Langmuir. 2009;25(12):6997-7005.
24. Michel R, Gradzielski M. Experimental aspects of colloidal interactions in mixed systems of liposome and inorganic nanoparticle and their applications. Int J Mol Sci. 2012;13(9):11610-11642.
25. Laurencin M, Georgelin T, Malezieux B, Siaugue JM, Menager C. Interactions between giant unilamellar vesicles and charged core-shell magnetic nanoparticles. Langmuir. 2010;26(20):16025-16030.
26. Schulz M, Olubummo A, Binder WH. Beyond the lipid-bilayer: interaction of polymers and nanoparticles with membranes. Soft Matter. 2012;8(18):4849-4864.
27. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano. 2011;5(2):1366-1375.
28. Albanese A, Chan WC. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano. 2011;5(7):5478-5489.
29. Zook JM, MacCuspie RI, Locascio LE, Halter MD, Elliott JT. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology. 2011;5(4):517-530.
30. Mahon E, Salvati A, Bombelli FB, Lynch I, Dawson KA. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release. 2012;161(2):164-174.
31. Velikonja A, Perutkova S, Gongadze E, et al. Monovalent ions and water dipoles in contact with dipolar zwitterionic lipid headgroups-theory and MD simulations. Int J Mol Sci. 2013;14(2):2846-2861.
32. Iglic A. A possible mechanism determining the stability of spiculated red blood cells. J Biomech. 1997;30(1):35-40.
33. Hagerstrand H, Danieluk M, Bobrowska-Hagerstrand M, et al. Influence of band 3 protein absence and skeletal structures on amphiphile-and Ca2+-induced shape alterations in erythrocytes: a study with lamprey (Lampetra fluviatilis), trout (Onchorhynchus mykiss) and human erythrocytes. Biochim Biophys Acta. 2000;1466(1-2):125-138.
34. Asharani PV, Sethu S, Vadukumpully S, et al. Investigations on the structural damage in human erythrocytes exposed to silver, gold, and platinum nanoparticles. Adv Funct Mater. 2010;20(8):1233-1242.
35. Han Y, Wang X, Dai H, Li S. Nanosize and surface charge effects of hydroxyapatite nanoparticles on red blood cell suspensions. ACS Appl Mater Interfaces. 2012;4(9):4616-4622.
36. Li SQ, Zhu RR, H, et al. Nanotoxicity of TiO(2) nanoparticles to erythrocyte in vitro. Food Chem Toxicol. 2008;46(12):3626-3631.
37. Šimundić M, Drašler B, Šuštar V, et al. Effect of engineered TiO2 and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles. BMC Vet Res. 2013;9:7.
38. Pavan C, Tomatis M, Ghiazza M, et al. In search of the chemical basis of the hemolytic potential of silicas. Chem Res Toxicol. 2013;26(8): 1188-1198.
39. Mai TD, d'Orlyé F, Ménager C, Varenne A, Siaugue JM. Red blood cells decorated with functionalized core-shell magnetic nanoparticles: elucidation of the adsorption mechanism. Chem Commun (Camb). 2013;49(47):5393-5395.
40. Campelj S, Makovec D, Drofenik M. Preparation and properties of water-based magnetic fluids. J Phys Condens Matter. 2008;20(20):204101.
41. Gyergyek S, Drofenik M, Makovec D. Oleic-acid-coated CoFe2O4 nanoparticles synthesized by co-precipitation and hydrothermal synthesis. Mater Chem Phys. 2012;133(1):515-522.
42. Campelj S, Makovec D, Bele M, Drofenik M, Jamnik J. Synthesis of magnetic nanoparticles functionalized with thin layer of silica. Mater Technol. 2007;41(2):103-107.
43. Cullity BD, Stock SR. Elements of X-ray Diffraction. 3rd ed. Reading MA, USA: Addison-Wesley Publishing Company, Inc; 1987.
44. Cheary RW, Coelho A. A fundamental parameters approach to x-ray line-profile fitting. J Appl Crystallogr. 1992;25:109-121.
45. Angelova MI, Dimitrov DS. Liposome electroformation. Faraday Discuss. 1986;81:303-311.
46. Zupanc J, Drobne D, Drasler B, et al. Experimental evidence for the interaction of C-60 fullerene with lipid vesicle membranes. Carbon. 2012;50(3):1170-1178.
47. Laggner P, Mio H. SWAX-a dual-detector camera for simultaneous small-angle and wide-angle x-ray-diffraction in polymer and liquid-crystal research. Nucl Instrum Methods Phys Res A. 1992;323(1-2): 86-90.
48. Huang TC, Toraya H, Blanton TN, Wu Y. X-ray-powder diffraction analysis of silver behenate, a possible low-angle diffraction standard. J Appl Crystallogr. 1993;26:180-184.
49. Klug HP, Alexander LE. X-ray Diffraction Procedures: For Polycrystalline and Amorphous Materials. 2nd ed. New York, NY, USA: John Wiley and Sons, Inc.; 1974.
50. Rudenko SV. Erythrocyte morphological states, phases, transitions and trajectories. Biochim Biophys Acta. 2010;1798(9):1767-1778.
51. Dobrovoiskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008;8(8):2180-2187.
52. Hidber PC, Graule TJ, Gauckler LJ. Citric acid-a dispersant for aqueous alumina suspensions. J Am Ceram Soc. 1996;79(7):1857-1867.
53. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 2011;123(1):133-143.
54. Lipowsky R, Sackmann E. Structure and Dynamics of Membranes. 1st ed. Elsevier Science: North Holland; 1995.
55. Iglic A, Slivnika T, Kralj-Iglic V. Elastic properties of biological membranes influenced by attached proteins. J Biomech. 2007;40(11): 2492-2500.
56. Kabaso D, Gongadze E, Elter P, et al. Attachment of rod-like (BAR) proteins and membrane shape. Mini Rev Med Chem. 2011;11(4): 272-282.
57. Dobereiner HG, Evans E, Kraus M, Seifert U, Wortis M. Mapping vesicle shapes into the phase diagram: a comparison of experiment and theory. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1997;55(4):4458-4474.
58. Ruiz-Herrero T, Velasco E, Hagan MF. Mechanisms of budding of nanoscale particles through lipid bilayers. J Phys Chem B. 2012;116(32): 9595-9603.
59. Alexeev A, Uspal WE, Balazs AC. Harnessing Janus nanoparticles to create controllable pores in membranes. ACS Nano. 2008;2(6): 1117-1122.
60. Zhang S, Nelson A, Beales PA. Freezing or wrapping: the role of particle size in the mechanism of nanoparticle-biomembrane interaction. Langmuir. 2012;28(35):12831-12837.
61. Jing B, Zhu Y. Disruption of supported lipid bilayers by semihydrophobic nanoparticles. J Am Chem Soc. 2011;133(28):10983-10989.
62. Ginzburg VV, Balijepalli S. Modeling the thermodynamics of the interaction of nanoparticles with cell membranes. Nano Lett. 2007;7(12):3716-3722.
63. Mecke A, Majoros IJ, Patri AK, Baker JR Jr, Holl MM, Orr BG. Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir. 2005;21(23):10348-10354.
64. Chen J, Hessler JA, Putchakayala K, et al. Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J Phys Chem B. 2009;113(32):11179-11185.
65. Hodzic A, Zoumpoulakis P, Pabst G, Mavromoustakos T, Rappolt M. Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions. Phys Chem Chem Phys. 2012;14(14):4780-4788.
66. Sheetz MP, Singer SJ. Biological-membranes as bilayer couples-molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A. 1974;71(11):4457-4461.
67. Betz T, Bakowsky U, Müller MR, Lehr CM, Bernhardt I. Conformational change of membrane proteins leads to shape changes of red blood cells. Bioelectrochemistry. 2007;70(1):122-126.
68. Soler MA, Báo SN, Alcântara GB, et al. Interaction of erythrocytes with magnetic nanoparticles. J Nanosci Nanotechnol. 2007;7(3): 1069-1071.
69. Bregar VB, Lojk J, Suštar V, Veranic P, Pavlin M. Visualization of internalization of functionalized cobalt ferrite nanoparticles and their intracellular fate. Int J Nanomedicine. 2013;8:919-931.